Holder plans sale of 5,000 common shares

A holder filed a notice to sell 5,000 shares of the issuer’s common stock through Morgan Stanley Smith Barney, with an aggregate market value of $617,500 on NASDAQ.

Rhea-AI Filing Summary

A holder filed a notice to sell 5,000 shares of the issuer’s common stock through Morgan Stanley Smith Barney, with an aggregate market value of $617,500 on NASDAQ.

The 5,000 shares are to be sold after being acquired the same day via a stock option exercise paid in cash. The issuer has 1,240,679,623 common shares outstanding. During the prior three months, the same seller, identified as Jeffrey Bluestone of Foster City, California, sold 5,000 common shares for gross proceeds of $625,400.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does this Form 144 filing related to GILD represent?

It is a notice that a holder intends to sell 5,000 shares of the issuer’s common stock on NASDAQ, with the proposed sale handled by Morgan Stanley Smith Barney for an aggregate market value of $617,500.

How many GILD common shares are planned for sale and at what value?

The notice covers 5,000 shares of common stock, with an aggregate market value listed as $617,500 for the planned NASDAQ sale.

How were the 5,000 GILD shares to be sold acquired?

The 5,000 common shares were acquired on 01/20/2026 through a stock option exercise from the issuer, with the purchase price paid in cash on the same date.

What is the total number of GILD shares outstanding mentioned in the filing?

The filing states that 1,240,679,623 shares of the issuer’s common stock are outstanding.

Has the seller made other GILD stock sales in the last three months?

Yes. The filing reports that Jeffrey Bluestone sold 5,000 common shares on 11/28/2025, generating gross proceeds of $625,400.

Which broker and exchange are involved in this GILD share sale notice?

The proposed sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ exchange.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/20/2026 - 04:01 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001771814
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	GILEAD SCIENCES, INC.
SEC File Number	000-19731
Address of Issuer	333 Lakeside Drive Foster City CALIFORNIA 94404
Phone	(650) 574-3000
Name of Person for Whose Account the Securities are To Be Sold	JEFFREY BLUESTONE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5000	617500.00	1240679623	01/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/20/2026	Stock Option Exercise	ISSUER			5000	01/20/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JEFFREY BLUESTONE 333 Lakeside Drive Foster City CA 94404	Common	11/28/2025	5000	625400.00

144: Remarks and Signature

Remarks
Date of Notice	01/20/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/13/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jeffrey Bluestone
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)